{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:00:32Z","timestamp":1792569632180,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:00:00Z","timestamp":1587168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:00:00Z","timestamp":1587168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10554-020-01847-z","type":"journal-article","created":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T11:02:27Z","timestamp":1587207747000},"page":"1465-1476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Left ventricular radial strain impairment precedes hypertrophy in Anderson\u2013Fabry disease"],"prefix":"10.1007","volume":"36","author":[{"given":"Letizia","family":"Spinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Imbriaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ponsiglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cuocolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Trimarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,18]]},"reference":[{"key":"1847_CR1","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ (2008) Fabry\u2019s disease. Lancet 372:1427\u20131435","journal-title":"Lancet"},{"key":"1847_CR2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","volume":"138","author":"RJ Desnick","year":"2003","unstructured":"Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338\u2013346","journal-title":"Ann Intern Med"},{"key":"1847_CR3","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","volume":"24","author":"JC Moon","year":"2003","unstructured":"Moon JC, Sachdev B, Elkington AG, McKenna WJ, Mehta A, Pennell DJ, Leed PJ, Elliott PM (2003) Gadolinium enhanced cardiovascular magnetic resonance in anderson-fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 24:2151\u20132155","journal-title":"Eur Heart J"},{"key":"1847_CR4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jacc.2010.11.018","volume":"57","author":"MR Patel","year":"2011","unstructured":"Patel MR, Cecchi F, Cizmarik M, Kantola I, Linhart A, Nicholls K, Strotmann J, Tallaj J, Tran TC, West ML, Beitner-Johnson D, Abiose A (2011) Cardiovascular events in patients with fabry disease natural history data from the fabry registry. J Am Coll Cardiol 57:1093\u20131099","journal-title":"J Am Coll Cardiol"},{"key":"1847_CR5","doi-asserted-by":"crossref","first-page":"e0182379","DOI":"10.1371\/journal.pone.0182379","volume":"12","author":"M Arends","year":"2017","unstructured":"Arends M, Biegstraaten M, Hughes DA, Mehta A, Elliott PM, Oder D, Watkinson OT, Vaz FM, van Kuilenburg ABP, Wanner C, Hollak CEM (2017) Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: analysis of prognostic factors. PLoS ONE 12:e0182379","journal-title":"PLoS ONE"},{"key":"1847_CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.echo.2010.02.015","volume":"23","author":"H Geyer","year":"2010","unstructured":"Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta PP (2010) Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr 23:351\u2013368","journal-title":"J Am Soc Echocardiogr"},{"key":"1847_CR7","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.echo.2013.09.005","volume":"26","author":"M Shanks","year":"2013","unstructured":"Shanks M, Thompson RB, Paterson ID, Putko B, Khan A, Chan A, Becher H, Oudit GY (2013) Systolic and diastolic function assessment in Fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements. J Am Soc Echocardiogr 26:1407\u20131414","journal-title":"J Am Soc Echocardiogr"},{"key":"1847_CR8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1540-8175.2012.01704.x","volume":"29","author":"C Gruner","year":"2012","unstructured":"Gruner C, Verocai F, Carasso S, Vannan MA, Jamorski M, Clarke JT, Care M, Iwanochko RM, Rakowski H (2012) Systolic myocardial mechanics in patients with Anderson\u2013Fabry disease with and without left ventricular hypertrophy and in comparison to nonobstructive hypertrophic cardiomyopathy. Echocardiography 29:810\u2013817","journal-title":"Echocardiography"},{"key":"1847_CR9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/ehjci\/jey108","volume":"20","author":"R Esposito","year":"2019","unstructured":"Esposito R, Galderisi M, Santoro C, Imbriaco M, Riccio E, Maria Pellegrino A, Sorrentino R, Lembo M, Citro R, Angela Losi M, Spinelli L, Trimarco B, Pisani A (2019) Prominent longitudinal strain reduction of left ventricular basal segments in treatment na\u00efve Anderson\u2013Fabry disease patients. Eur Heart J Cardiovasc Imaging 20:438\u2013445","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1847_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-019-01734-8","author":"L Spinelli","year":"2019","unstructured":"Spinelli L, Imbriaco M, Giugliano G, Nappi C, Gaudieri V, Riccio E, Pisani A, Trimarco B, Cuocolo A (2019) Focal reduction in left ventricular 123I-metaiodobenzylguanidine uptake and impairment in systolic function in patients with Anderson\u2013Fabry disease. J Nucl Cardiol. https:\/\/doi.org\/10.1007\/s12350-019-01734-8","journal-title":"J Nucl Cardiol"},{"key":"1847_CR11","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/echo.12216","volume":"30","author":"MC Saccheri","year":"2013","unstructured":"Saccheri MC, Cianciulli TF, Lax JA, Gagliardi JA, C\u00e1ceres GL, Quarin AE, Kisinovsky I, Rozenfeld PA, Reisin RC, AADELFA (2013) Two-dimensional speckle tracking echocardiography for early detection of myocardial damage in young patients with Fabry disease. Echocardiography 30:1069\u20131077","journal-title":"Echocardiography"},{"key":"1847_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.007019","author":"L Spinelli","year":"2018","unstructured":"Spinelli L, Imbriaco M, Nappi C, Nicolai E, Giugliano G, Ponsiglione A, Diomiaiuti TC, Riccio E, Duro G, Pisani A, Trimarco B, Cuocolo A (2018) Early cardiac involvement affects left ventricular longitudinal function in females carrying \u03b1-galactosidase A mutation: role of hybrid positron emission tomography and magnetic resonance imaging and speckle tracking echocardiography. Circ Cardiovasc Imaging. https:\/\/doi.org\/10.1161\/CIRCIMAGING.117.007019","journal-title":"Circ Cardiovasc Imaging"},{"key":"1847_CR13","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/echo.13496","volume":"34","author":"F Labombarda","year":"2017","unstructured":"Labombarda F, Saloux E, Milesi G, Bienvenu B (2017) Loss of base-to-apex circumferential strain gradient: a specific pattern of Fabry cardiomyopathy? Echocardiography 34:504\u2013510","journal-title":"Echocardiography"},{"key":"1847_CR14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10554-014-0551-4","volume":"31","author":"DA Morris","year":"2015","unstructured":"Morris DA, Blaschke D, Canaan-K\u00fchl S, Krebs A, Knobloch G, Walter TC, Haverkamp W (2015) Global cardiac alterations detected by speckle-tracking echocardiography in Fabry disease: left ventricular, right ventricular, and left atrial dysfunction are common and linked to worse symptomatic status. Int J Cardiovasc Imaging 31:301\u2013313","journal-title":"Int J Cardiovasc Imaging"},{"key":"1847_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) and CKD Work Group","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) and CKD Work Group (2013) KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 3:1\u2013150","journal-title":"Kidney Int"},{"key":"1847_CR16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233\u2013270","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1847_CR17","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0735-1097(92)90385-Z","volume":"20","author":"G de Simone","year":"1992","unstructured":"de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251\u20131260","journal-title":"J Am Coll Cardiol"},{"key":"1847_CR18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00259-015-3273-5","volume":"43","author":"L Spinelli","year":"2016","unstructured":"Spinelli L, Pellegrino T, Pisani A, Giudice CA, Riccio E, Imbriaco M, Trimarco B, Cuocolo A (2016) Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123) I-meta-iodobenzylguanidine imaging in Anderson\u2013Fabry disease. Eur J Nucl Med Mol Imaging 43:729\u2013739","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1847_CR19","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.jacc.2016.07.741","volume":"68","author":"S Nordin","year":"2016","unstructured":"Nordin S, Kozor R, Bulluck H, Castelletti S, Rosmini S, Abdel-Gadir A, Baig S, Mehta A, Hughes D, Moon JC (2016) Cardiac Fabry disease with late gadolinium enhancement is a chronic inflammatory cardiomyopathy. J Am Coll Cardiol 68:1705\u20131711","journal-title":"J Am Coll Cardiol"},{"key":"1847_CR20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2011.06.021","volume":"104","author":"MA Torralba-Cabeza","year":"2011","unstructured":"Torralba-Cabeza MA, Olivera S, Hughes DA, Pastores GM, Mateo RN, Perez-Calvo J (2011) Cystatin C and NT-proBNP as prognostic biomarkers in Fabry disease. Mol Genet Metab 104:301\u2013307","journal-title":"Mol Genet Metab"},{"key":"1847_CR21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.amjcard.2012.08.055","volume":"111","author":"CJ Coats","year":"2013","unstructured":"Coats CJ, Parisi V, Ramos M, Janagarajan K, O\u2019Mahony C, Dawnay A, Lachmann RH, Murphy E, Mehta A, Hughes D, Elliott PM (2013) N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement of anderson-fabry disease. Am J Cardiol 111:111\u2013117","journal-title":"Am J Cardiol"},{"key":"1847_CR22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/heartjnl-2018-313699","volume":"105","author":"R Vijapurapu","year":"2019","unstructured":"Vijapurapu R, Nordin S, Shanat Baig S, Liu B, Rosmini S, Augusto J, Tchan M, Hughes DA, Geberhiwot T, Moon JC, Steeds RP, Kozor R (2019) Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease. Heart 105:470\u2013476","journal-title":"Heart"},{"key":"1847_CR23","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s10554-019-01668-9","volume":"35","author":"GM Santambrogio","year":"2019","unstructured":"Santambrogio GM, Maloberti A, Vallerio P, Peritore A, Span\u00f2 F, Occhi L, Musca F, Belli O, De Chiara B, Casadei F, Facchetti R, Turazza F, Manfredini E, Giannattasio C, Moreo A (2019) Could two-dimensional radial strain be considered as a novel tool to identify pre-clinical hypertrophic cardiomyopathy mutation carriers? Int J Cardiovasc Imaging 35:2167\u20132175","journal-title":"Int J Cardiovasc Imaging"},{"key":"1847_CR24","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","volume":"108","author":"F Weidemann","year":"2003","unstructured":"Weidemann F, Breunig F, Beer M, Sandstede J, Turschner O, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM (2003) Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 108:1299\u20131301","journal-title":"Circulation"},{"key":"1847_CR25","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.echo.2008.07.016","volume":"21","author":"Y Mizuguchi","year":"2008","unstructured":"Mizuguchi Y, Oishi Y, Miyoshi H, Iuchi A, Nagase N, Oki T (2008) The functional role of longitudinal, circumferential, and radial myocardial deformation for regulating the early impairment of left ventricular contraction and relaxation in patients with cardiovascular risk factors: a study with two-dimensional strain imaging. J Am Soc Echocardiogr 21:1138\u20131144","journal-title":"J Am Soc Echocardiogr"},{"key":"1847_CR26","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/eurheartj\/ehn141","volume":"29","author":"J Wang","year":"2008","unstructured":"Wang J, Khoury DS, Yue Y, Torre-Amione G, Nagueh SF (2008) Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J 29:1283\u20131289","journal-title":"Eur Heart J"},{"key":"1847_CR27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jjcc.2011.08.003","volume":"59","author":"K Nishimura","year":"2012","unstructured":"Nishimura K, Okayama H, Inoue K, Saito M, Yoshii T, Hiasa G, Sumimoto T, Inaba S, Ogimoto A, Funada J, Higaki J (2012) Direct measurement of radial strain in the inner-half layer of the left ventricular wall in hypertensive patients. J Cardiol 59:64\u201371","journal-title":"J Cardiol"},{"key":"1847_CR28","first-page":"743","volume":"34","author":"MMP van den Dorpel","year":"2018","unstructured":"van den Dorpel MMP, Heinonen I, Snelder SM, Vos HJ, Sorop O, van Domburg RT, Merkus D, Duncker DJ, van Dalen BM (2018) Early detection of left ventricular diastolic dysfunction using conventional and speckle tracking echocardiography in a large animal model of metabolic dysfunction. Int J Cardiovasc Imaging 34:743\u2013749","journal-title":"Int J Cardiovasc Imaging"},{"key":"1847_CR29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/ejechocard\/jeq014","volume":"11","author":"P Lancellotti","year":"2010","unstructured":"Lancellotti P, Donal E, Magne J, O\u2019Connor K, Moonen ML, Cosyns B, Pierard LA (2010) Impact of global left ventricular afterload on left ventricular function in asymptomatic severe aortic stenosis: a two-dimensional speckle-tracking study. Euro J Echocardiogr 11:537\u2013543","journal-title":"Euro J Echocardiogr"},{"key":"1847_CR30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/CIRCIMAGING.113.000842","volume":"7","author":"JA Urbano-Moral","year":"2014","unstructured":"Urbano-Moral JA, Rowin EJ, Maron MS, Crean A, Pandian NG (2014) Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 7:11\u201319","journal-title":"Circ Cardiovasc Imaging"},{"key":"1847_CR31","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-2362.2008.02053.x","volume":"38","author":"L Spinelli","year":"2008","unstructured":"Spinelli L, Nicolai E, Acampa W, Imbriaco M, Pisani A, Rao MA, Scopacasa F, Cianciaruso B, De Luca N, Cuocolo A (2008) Cardiac performance during exercise in patients with Fabry\u2019s disease. Eur J Clin Invest 38:910\u2013917","journal-title":"Eur J Clin Invest"},{"key":"1847_CR32","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","volume":"105","author":"JM Aerts","year":"2008","unstructured":"Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, van Roomen C, Mirzaian M, Wijburg FA, Linthorst GE, Vedder AC, Rombach SM, Cox-Brinkman J, Somerharju P, Boot RG, Hollak CE, Brady RO, Poorthuis BJ (2008) Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci USA 105:2812\u20132817","journal-title":"Proc Natl Acad Sci USA"},{"key":"1847_CR33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehp387","volume":"31","author":"N Brakch","year":"2010","unstructured":"Brakch N, Dormond O, Bekri S, Golshayan D, Correvon M, Mazzolai L, Steinmann B, Barbey F (2010) Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease. Eur Heart J 31:67\u201376","journal-title":"Eur Heart J"},{"key":"1847_CR34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.ATV.0000209649.60409.38","volume":"26","author":"F Barbey","year":"2006","unstructured":"Barbey F, Brakch N, Linhart A, Rosenblatt-Velin N, Jeanrenaud X, Qanadli S, Steinmann B, Burnier M, Palecek T, Bultas J, Hayoz D (2006) Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol 26:839\u2013844","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1847_CR35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10545-006-0473-y","volume":"30","author":"T Heare","year":"2007","unstructured":"Heare T, Alp NJ, Priestman DA, Kulkarni AB, Qasba P, Butters TD, Dwek RA, Clarke K, Channon KM, Platt FM (2007) Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease: partial prevention by N-butyldeoxynojirimycin treatment. J Inherit Metab Dis 30:79\u201387","journal-title":"J Inherit Metab Dis"},{"key":"1847_CR36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/cvr\/cvq333","volume":"89","author":"S Park","year":"2011","unstructured":"Park S, Kim JA, Joo KY, Choi S, Choi EN, Shin JA, Han KH, Jung SC, Suh SH (2011) Globotriaosylceramide leads to K(Ca)3.1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease. Cardiovasc Res 89:290\u2013299","journal-title":"Cardiovasc Res"},{"key":"1847_CR37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","volume":"95","author":"JS Shen","year":"2008","unstructured":"Shen JS, Meng XL, Moore DF, Quirk JM, Shayman JA, Schiffmann R, Kaneski CR (2008) Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells. Mol Genet Metab 95:163\u2013168","journal-title":"Mol Genet Metab"},{"key":"1847_CR38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2004.01.011","volume":"82","author":"T Lucke","year":"2004","unstructured":"Lucke T, Hoppner W, Schmidt E, Illsinger S, Das AM (2004) Fabry disease: reduced activities of respiratory chain enzymes with decreased levels of energy-rich phosphates in fibroblasts. Mol Genet Metab 82:93\u201397","journal-title":"Mol Genet Metab"},{"key":"1847_CR39","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/eurjhf\/hfq211","volume":"13","author":"W Machann","year":"2011","unstructured":"Machann W, Breunig F, Weidemann F, Sandstede J, Hahn D, K\u00f6stler H, Neubauer S, Wanner C, Beer M (2011) Cardiac energy metabolism is disturbed in Fabry disease and improves with enzyme replacement therapy using recombinant human galactosidase A. Eur J Heart Fail 13:278\u2013283","journal-title":"Eur J Heart Fail"},{"key":"1847_CR40","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00259-015-3036-3","volume":"42","author":"C Nappi","year":"2015","unstructured":"Nappi C, Altiero M, Imbriaco M, Nicolai E, Giudice CA, Aiello M, Diomiaiuti CT, Pisani A, Spinelli L, Cuocolo A (2015) First experience of simultaneous PET\/MRI for the early detection of cardiac involvement in patients with Anderson\u2013Fabry disease. Eur J Nucl Med Mol Imaging 42:1025\u20131031","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1847_CR41","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s10753-015-0214-1","volume":"38","author":"Y Hayashi","year":"2015","unstructured":"Hayashi Y, Hanawa H, Jiao S, Hasegawa G, Ohno Y, Yoshida K, Suzuki T, Kashimura T, Obata H, Tanaka K, Watanabe T, Minamino T (2015) Elevated endomyocardial biopsy macrophage-related markers in intractable myocardial diseases. Inflammation 38:2288\u20132299","journal-title":"Inflammation"},{"key":"1847_CR42","doi-asserted-by":"crossref","first-page":"1221.e1","DOI":"10.1016\/j.cjca.2015.10.033","volume":"32","author":"KH Chen","year":"2016","unstructured":"Chen KH, Chien Y, Wang KL, Leu HB, Hsiao CY, Lai YH, Wang CY, Chang YL, Lin SJ, Niu DM, Chiou SH, Yu WC (2016) Evaluation of proinflammatory prognostic biomarkers for Fabry cardiomyopathy with enzyme replacement therapy. Can J Cardiol 32:1221.e1-1221.e9","journal-title":"Can J Cardiol"},{"key":"1847_CR43","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/ehjci\/jez041","volume":"20","author":"MS Amzulescu","year":"2019","unstructured":"Amzulescu MS, De Craene M, Langet H, Pasquet A, Vancraeynest D, Pouleur AC, Vanoverschelde JL, Gerber BL (2019) Myocardial strain imaging: review of general principles, validation, and sources of discrepancies. Eur Heart J Cardiovasc Imaging 20:605\u2013619","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1847_CR44","first-page":"98","volume":"43","author":"H Teraguchi","year":"2004","unstructured":"Teraguchi H, Tekenaka T, Yoshida A, Taguchi S, Ninomiya K, Yoshida H, Horinouchi M, Yonezawa S, Nakao S, Minagoe S, Tei S (2004) End-stage cardiac manifestations and autopsy findings in patients with cardiac Fabry disease. J Cardiol 43:98\u201399","journal-title":"J Cardiol"},{"key":"1847_CR45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.amjcard.2006.07.088","volume":"99","author":"M Kawano","year":"2007","unstructured":"Kawano M, Takenaka T, Otsuji Y, Teraguchi H, Yoshifuku S, Yuasa T, Yu B, Miyata M, Hamasaki S, Minagoe S, Kanmura Y, Tei C (2007) Significance of asymmetric basal posterior wall thinning in patients with cardiac Fabry\u2019s disease. Am J Cardiol 99:261\u2013263","journal-title":"Am J Cardiol"},{"key":"1847_CR46","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","volume":"6","author":"DM Sado","year":"2013","unstructured":"Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD, Lachmann RH, Murphy E, Mehta A, Hughes D, Neubauer S, Elliott PM, Moon JC (2013) Identification and assessment of Anderson\u2013Fabry disease by cardiovascular magnetic resonance non-contrast myocardial T1 mapping. Circ Cardiovasc Imaging 6:392\u2013398","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-020-01847-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-020-01847-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-020-01847-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T07:27:43Z","timestamp":1722756463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-020-01847-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,18]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1847"],"URL":"https:\/\/doi.org\/10.1007\/s10554-020-01847-z","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"value":"1569-5794","type":"print"},{"value":"1573-0743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,18]]},"assertion":[{"value":"14 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}